Based on this reasoning, we selected ZNF671 and TENC1 promoter methylation as putative markers of Epi‐Basal breast cancers from the top promoter methylation events identified as significantly associated with tumors classified as Epi‐Basal (Supplementary Table 3). Here, ZNF671 is linked to breast carcinoma.